(Press-News.org) At the 18th World Congress on Polyphenols Applications, which will be held in Malta on October 2-3, 2025, Iprona and Polyphenols Applications will announce a global call to action, inviting researchers to strengthen the quality and reproducibility of polyphenol science.
Through this initiative, ElderCraft®, a polyphenol-standardised European black elderberry (Sambucus nigra) water extract, is now available at no cost to qualified academic and clinical research groups worldwide.
ElderCraft® is a polyphenol and anthocyanin-rich extract, sourced exclusively from Austrian elderberries and produced using gentle ultrafiltration to preserve the natural profile of bioactive compounds. Each batch comes with Certificates of Analysis (CoAs), HPLC fingerprints, and stability data, ensuring traceability, batch-to-batch consistency, and study-ready analytics.
“Robust, comparable data begins with robust, comparable materials,” said Dr. Stephan Plattner, Scientific Director, Health & Nutrition Ingredients at iprona. “By sharing ElderCraft® with the research community, we aim to reduce study-to-study variability, enable stronger meta-analyses, and help unlock clearer dose–response and subgroup insights in polyphenol science.”
Polyphenols Applications 2025, organiser of the World Congress on Polyphenols Applications, fully supports this effort and encourages researchers across mechanistic, preclinical, and clinical fields to integrate highly characterised, standardised polyphenol extracts into their work.
Why It Matters
Improved reproducibility: Tight batch tolerances and full analytics reduce variability between studies.
Meta-analysis ready: Standardisation enables stronger dose–response and subgroup evaluation.
Translational relevance: ElderCraft® is already used in global consumer products, connecting research to real-world impact.
Compliance support: Full traceability and documented quality facilitate ethical and regulatory submissions.
Research areas include immune function, gut microbiome modulation, viral defence, cardiometabolic health, cognitive performance, healthy ageing, and energy metabolism.
Request research material Link:
https://www.craft-ingredients.info/references/eldercraft-research-material-request
Contact
Scientific queries/material: Dr. Stephan Plattner (Scientific Director, Health & Nutrition Ingredients, Iprona Lana) – stephan.plattner@iprona.com
About ElderCraft®
https://www.craft-ingredients.info/our-ingredients/eldercraft
The 18th World Congress on Polyphenols Applications is the global forum where polyphenol science meets clinical translation. By joining forces, iprona and Polyphenols Applications aim to accelerate high-quality, reproducible studies that advance the field and clarify the health potential of polyphenols.
About iprona
Iprona is a global leader in fruit processing and bioactive ingredient development. With decades of expertise in polyphenol-rich extracts, iprona supports science-driven innovation and the creation of evidence-based health applications.
About Polyphenols Applications
Polyphenols Applications is an international scientific platform and organiser of the World Congress on Polyphenols Applications, fostering collaboration among researchers, clinicians, and industry to advance understanding and application of polyphenols in health and disease.
www.polyphenols-site.com
Disclosure: ElderCraft® is provided by iprona for research use only. This announcement is issued in collaboration with Polyphenols Applications and supported by iprona.
END
Polyphenols Applications World Congress and Iprona will launch Global Call to Advance Robust, Reproducible Polyphenol Research, next October in Malta
A standardized, reproducible, traceable extract for research groups across the globe
2025-09-29
ELSE PRESS RELEASES FROM THIS DATE:
Adaptive radiation therapy increases safety and preserves quality of life, says study
2025-09-29
For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or enmeshed within the bowel. Given their radioresistant nature they require high doses of radiation that risk damaging healthy nearby tissue. Once patients have undergone an initial radiation course, doctors are often left with no safe radiation treatment option.
But a pilot study from Fox Chase Cancer Center, presented at the 2025 American ...
Electric space heating, appliances reduce US residential energy consumption
2025-09-29
UNIVERSITY PARK, Pa. — Electric space heating systems and appliances like water heaters can help American homeowners reduce their energy use, and possibly their utility bills, according to a team led by researchers at Penn State.
The researchers set out to identify the most important factors driving U.S. on-site residential energy consumption, which the team said accounts for approximately 21% of primary energy consumption in the country and is more complex than commercial energy use. They found that electric heating systems like heat pumps, compared to systems that rely on natural gas and oil, had the largest impact on reducing on-site energy ...
Could your next job interview be with a chatbot? New study seeks to help bring fairness into AI-powered hiring
2025-09-29
Landing a job traditionally meant polishing a resume, printing extra copies and sitting across from a hiring manager. Today, the first “person” to evaluate you might not be a person at all — it could be a chatbot powered by artificial intelligence. These automated systems can ask questions, score responses and even recommend who gets hired.
Rice University’s Tianjun Sun has received a National Science Foundation award to lead a two-year collaborative project with the University of Florida examining how AI interview systems work — and how to make them more fair.
For employers, chatbot interviews promise consistency ...
Intensity-modulated radiation therapy (IMRT) matches proton therapy in patient-reported outcomes for oropharyngeal cancer
2025-09-29
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people with locally advanced oropharyngeal cancer. The TORPEdO trial, a randomized study conducted across the United Kingdom, found no meaningful differences between the treatments in patient-reported quality of life, swallowing function or feeding tube dependence at one year.
Both advanced radiation approaches resulted in excellent ...
Radiation therapy after surgery safely reduces pelvic relapse risk from locally advanced, muscle-invasive bladder cancer
2025-09-29
SAN FRANCISCO, September 29, 2025 — Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial. In the study, moderate doses of radiation therapy after bladder removal surgery sharply cut the rates of cancer returning in the pelvis without adding serious side effects. Findings of the Bladder Adjuvant RadioTherapy (BART) trial conducted at centers across India will be presented today at the American Society ...
Intensity modulated radiotherapy matches proton beam therapy for head and neck cancer
2025-09-29
Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer Research UK-funded clinical trial.
The TORPEdO trial funded by Cancer Research UK and The Taylor Family Foundation, led by The Christie NHS Foundation Trust and sponsored by the Institute of Cancer Research, London, compared two forms of highly targeted radiotherapy for head and neck cancer – proton beam therapy (PBT) and intensity-modulated radiotherapy (IMRT).
Presented at the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California, the initial results of ...
Simultaneous synthesis of all 21 types of tRNA in vitro
2025-09-29
Collaborative research by the University of Tokyo and RIKEN Center for Biosystems Dynamics Research has led to the development of a new method for simultaneously synthesizing all transfer RNA (tRNA) required for protein synthesis in a reconstituted translation system in vitro.
Currently, humans rely on living organisms (bacteria, yeast, plants, and animals) for the production of pharmaceuticals and food. However, living organisms are susceptible to environmental changes, breeding improvements require time, and ...
Renshaw receives funding for VISR 3.0: Learning management system development and implementation
2025-09-29
Keith Renshaw, Senior Associate Provost for Undergraduate Education, Office of the Provost, received funding for: “VISR 3.0: Learning Management System Development and Implementation.”
This project aims to train employees within a wide variety of agencies in a) identifying service members, veterans, and family members; b) screening for suicide risk; and c) providing appropriate referrals and/or interventions as needed.
VISR was first piloted in 2020, with good success.
From 2022-2023, Renshaw led a follow-up project dubbed “VISR 2.0” focused on evaluating VISR’s broader impact and identifying ways to increase the scale of the program. Results ...
Yang receives funding for welfare and poverty mapping project
2025-09-29
Yang Receives Funding For Welfare & Poverty Mapping Project
Ruixin Yang, Associate Professor, Geography Geoinformation Science, College of Science, received funding for: “Welfare and Poverty Mapping with Satellite-Derived Data, Spatial Analysis and Machine Learning Application.”
The objective of this consultancy is to provide technical and advisory support in:
processing satellite imagery and geospatial datasets;
designing and implementing machine learning models for spatial analysis; and
supporting ...
New BBRF webinar to explore biological factors underlying suicide risk
2025-09-29
Suicide is a leading cause of death in the United States. The Brain & Behavior Research Foundation (BBRF) will host a free webinar on Tuesday, October 14, 2025, at 2:00 pm ET, examining the biological factors that contribute to suicide risk and what can be done to strengthen prevention efforts. The event will be hosted by Jeffrey Borenstein, M.D., President & CEO of BBRF and host of the Emmy® nominated television series Healthy Minds.
Featured speaker, Steven Lamontagne, Ph.D., a postdoctoral fellow in the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health (NIMH), will ...
LAST 30 PRESS RELEASES:
Drug which stops tumors' blood supply could help kids with bone cancer live longer
Disrupted sleep in teens identified as suicide risk factor
Traffic noise joins land clearance as damaging to bird survival
Innovative online monitoring system for farmland non-point source pollution enables automated monitoring of continuous cropping farmland
Stabilized fertilizers improve nitrogen use efficiency and reduce greenhouse gas emissions
Endangered Kangaroo Island ground dweller found in trees
Guardians of the coast: Philippine scientists unlock the climate power of mangroves in Eastern Visayas
Nano-biochar helps rice roots turn silver ions into less toxic nanoparticles
New ‘liquid metal’ composite material enables recyclable, flexible and reconfigurable electronics
Extinction rates have slowed across many plant and animal groups, study shows
Tiny fossil bone helps unlock history of the bowerbird
AI tool beats humans at detecting parasites in stool samples, Utah study finds
Innovative biochar research to boost circular economy: Join live talk by Prof. Salah Jellali on October 29
Early life sugar restriction linked to lasting heart benefits in adulthood
The Lancet: Study confirms cardiovascular benefits of semaglutide beyond weight loss
‘Weight loss’ drug helps heart regardless of amount of weight lost
First truly global picture of wide inequalities in care for women’s cancers
International Consortium of Women’s Mental Health Experts present scientific evidence to support classification of postpartum psychosis as a distinct disease
PET imaging of inflammation predicts recovery, guides therapy after heart attack
Pennington Biomedical awarded renewal of NIH-funded Center to Advance Metabolic Disease Research and train future scientists
Planetary scientists link Jupiter’s birth to Earth’s formation zone
University of Louisville, UofL Health receive $11.5 million to develop new cancer immunotherapies
Survey: Californians don’t know cannabis driving laws
Gum disease and cavities linked to increased stroke risk
Gum disease associated with changes in the brain
Brian Cleary awarded $2.25 million NIH grant to advance single-cell gene expression research
Gut parasites identified from feces of ancient Mexican people
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program
Idiopathic hypersomnia is a rare disease of excessive sleepiness, with patients revealing they never feel rested or awake no matter how much sleep they get, in analysis of online posts
Backyard birders in South Africa may continue to enjoy biodiversity in visiting birds under climate change scenarios, while climate change and declining biodiversity may decrease birding in protected
[Press-News.org] Polyphenols Applications World Congress and Iprona will launch Global Call to Advance Robust, Reproducible Polyphenol Research, next October in MaltaA standardized, reproducible, traceable extract for research groups across the globe